Taigle has become a vendor partner of SAFE-BioPharma, the non-profit that manages the SAFE-BioPharma digital identity and signature standard for the biopharmaceutical and healthcare industries. The SAFE-BioPharma standard allows its member companies to meet security and confidentiality needs specific to the life sciences.
Taigle provides seamless and fully integrated software solutions to companies in the healthcare, financial services, media and entertainment, and other industries. The company’s MySignatureBook service, which allows people with interoperable digital identities to access and apply digital signatures to documents in the cloud, is being used by the National Cancer Institute, Bristol-Myers Squibb, and Sanofi-Aventis in their cloud-based research collaboration.
SAFE-BioPharma digital identities are interoperable with US government regulatory and other agencies and with other organizations across the life sciences and other industries.
“As a SAFE-BioPharma vendor partner we will be closer to the growing global community of companies and other organizations that use the standard to improve their operations,” said Ajit Sodhi, president, Taigle. “We are committed to helping members verify and manage digital identities and to apply SAFE-BioPharma digital signatures.”